• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸烟及合并症与土耳其接受治疗的565例新冠患者的病情严重程度及死亡率相关:一项回顾性观察研究。

Smoking and comorbidities are associated with COVID-19 severity and mortality in 565 patients treated in Turkey: a retrospective observational study.

作者信息

Caliskan Tayfun, Saylan Bengu

机构信息

Assistant Professor, Department of Pulmonology, Sultan 2. Abdulhamit Han Training and Research Hospital, Health Sciences University, Istanbul, Turkey.

Pulmonologist, Department of Pulmonology, Sultan 2. Abdulhamit Han Training and Research Hospital, Health Sciences University, Istanbul, Turkey.

出版信息

Rev Assoc Med Bras (1992). 2020 Dec;66(12):1679-1684. doi: 10.1590/1806-9282.66.12.1679.

DOI:10.1590/1806-9282.66.12.1679
PMID:33331576
Abstract

OBJECTIVE

We aimed to explore the prevalence of smoking rates and comorbidities and evaluate the relationship between them and disease severity and mortality in inpatients with COVID-19.

METHODS

COVID-19 patients were divided into the following groups: clinic group, intensive care unit (ICU) group, survivors, and non-survivors. Non-COVID-19 patients were included as a control group. The groups were compared.

RESULTS

There was no difference between patients with and without COVID-19 in terms of smoking, asthma, diabetes, dementia, coronary artery disease (CAD), hypertension, chronic renal failure and arrhythmia (p>0.05). Older age (Odds ratio (OR), 1.061; 95% confidence interval (CI): 1.041-1.082; p< 0.0001), chronic obstructive pulmonary disease (COPD) (OR, 2.775; 95% CI: 1.128-6.829; p=0.026) and CAD (OR, 2.696; 95% CI: 1.216-5.974; p=0.015) were significantly associated with ICU admission. Current smoking (OR, 5.101; 95% CI: 2.382-10.927; p<0.0001) and former smoking (OR, 3.789; 95% CI: 1.845-7.780; p<0.0001) were risk factors for ICU admission. Older age (OR; 1.082; 95% CI: 1.056-1.109; p<0.0001), COPD (OR, 3.213; 95% CI: 1.224-8.431; p=0.018), CAD (OR, 6.252; 95% CI: 2.171-18.004; p=0.001) and congestive heart failure (CHF) (OR, 5.917; 95% CI 1.069-32.258; p=0.042), were significantly associated with mortality. Current smoking (OR, 13.014; 95% CI: 5.058-33.480; p<0.0001) and former smoking (OR, 6.507; 95% CI 2.731-15.501; p<0.0001) were also risk factors for mortality.

CONCLUSION

Smoking, older age, COPD, and CAD were risk factors for ICU admission and mortality in patients with COVID-19. CHF was not a risk factor for ICU admission; however, it was a risk factor for mortality.

摘要

目的

我们旨在探讨新型冠状病毒肺炎(COVID-19)住院患者的吸烟率及合并症的流行情况,并评估它们与疾病严重程度及死亡率之间的关系。

方法

将COVID-19患者分为以下几组:门诊组、重症监护病房(ICU)组、存活者组和非存活者组。纳入非COVID-19患者作为对照组。对各组进行比较。

结果

COVID-19患者与非COVID-19患者在吸烟、哮喘、糖尿病、痴呆、冠状动脉疾病(CAD)、高血压、慢性肾衰竭和心律失常方面无差异(p>0.05)。高龄(优势比(OR),1.061;95%置信区间(CI):1.041-1.082;p<0.0001)、慢性阻塞性肺疾病(COPD)(OR,2.775;95%CI:1.128-6.829;p=0.026)和CAD(OR,2.696;95%CI:1.216-5.974;p=0.015)与入住ICU显著相关。当前吸烟者(OR,5.101;95%CI:2.382-10.927;p<0.0001)和既往吸烟者(OR,3.789;95%CI:1.845-7.780;p<0.0001)是入住ICU的危险因素。高龄(OR;1.082;95%CI:1.056-1.109;p<0.0001)、COPD(OR,3.213;95%CI:1.224-8.431;p=0.018)、CAD(OR,6.252;95%CI:2.171-18.004;p=0.001)和充血性心力衰竭(CHF)(OR,5.917;95%CI 1.069-32.258;p=0.042)与死亡率显著相关。当前吸烟者(OR,13.014;95%CI:5.058-33.480;p<0.0001)和既往吸烟者(OR,6.507;95%CI 2.731-15.501;p<0.0001)也是死亡的危险因素。

结论

吸烟、高龄、COPD和CAD是COVID-19患者入住ICU和死亡的危险因素。CHF不是入住ICU的危险因素;然而,它是死亡的危险因素。

相似文献

1
Smoking and comorbidities are associated with COVID-19 severity and mortality in 565 patients treated in Turkey: a retrospective observational study.吸烟及合并症与土耳其接受治疗的565例新冠患者的病情严重程度及死亡率相关:一项回顾性观察研究。
Rev Assoc Med Bras (1992). 2020 Dec;66(12):1679-1684. doi: 10.1590/1806-9282.66.12.1679.
2
How do COPD comorbidities affect ICU outcomes?慢性阻塞性肺疾病(COPD)的合并症如何影响重症监护病房(ICU)的治疗结果?
Int J Chron Obstruct Pulmon Dis. 2014 Oct 17;9:1187-96. doi: 10.2147/COPD.S70257. eCollection 2014.
3
Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19.大量 COVID-19 住院血液透析患者死亡的决定因素。
BMC Nephrol. 2021 Jan 14;22(1):29. doi: 10.1186/s12882-021-02233-0.
4
Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey.土耳其全国性分析:与无肾病患者相比,慢性肾脏病、血液透析和肾移植患者 COVID-19 感染的死亡率分析。
Nephrol Dial Transplant. 2020 Dec 4;35(12):2083-2095. doi: 10.1093/ndt/gfaa271.
5
Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness.哮喘患者的嗜酸性粒细胞增多对严重的COVID-19疾病具有保护作用。
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1152-1162.e3. doi: 10.1016/j.jaip.2020.12.045. Epub 2021 Jan 23.
6
The relationship between coronary artery disease and clinical outcomes in COVID-19: a single-center retrospective analysis.COVID-19 患者冠状动脉疾病与临床结局的关系:一项单中心回顾性分析。
Coron Artery Dis. 2021 Aug 1;32(5):367-371. doi: 10.1097/MCA.0000000000000934.
7
Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection.2019冠状病毒病(COVID-19)感染住院患者的冠状动脉疾病
Open Heart. 2020 Nov;7(2). doi: 10.1136/openhrt-2020-001428.
8
Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: risk factors for mortality.慢性阻塞性肺疾病患者因社区获得性肺炎入住重症监护病房:死亡的危险因素。
J Crit Care. 2013 Dec;28(6):975-9. doi: 10.1016/j.jcrc.2013.08.004. Epub 2013 Sep 24.
9
Clinical characteristics and outcomes of patients with Corona Virus Disease 2019 (COVID-19) at Mercy Health Hospitals, Toledo, Ohio.俄亥俄州托莱多市梅西健康医院 2019 年冠状病毒病(COVID-19)患者的临床特征和转归。
PLoS One. 2021 Apr 22;16(4):e0250400. doi: 10.1371/journal.pone.0250400. eCollection 2021.
10
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.美国 31461 例 COVID-19 成年人死亡相关合并症:一项联合电子病历分析。
PLoS Med. 2020 Sep 10;17(9):e1003321. doi: 10.1371/journal.pmed.1003321. eCollection 2020 Sep.

引用本文的文献

1
Prevalence of comorbidities and their association with disease severity and mortality in COVID-19 patients: A systematic review and meta-analysis.COVID-19患者合并症的患病率及其与疾病严重程度和死亡率的关联:一项系统综述和荟萃分析。
J Multimorb Comorb. 2025 Aug 28;15:26335565251371256. doi: 10.1177/26335565251371256. eCollection 2025 Jan-Dec.
2
Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis.既往冠心病对 COVID-19 患者预后的影响:系统评价和荟萃分析。
PLoS One. 2023 Oct 10;18(10):e0292021. doi: 10.1371/journal.pone.0292021. eCollection 2023.
3
A systematic review and meta-analysis on the prevalence and impact of coronary artery disease in hospitalized COVID-19 patients.
关于住院COVID-19患者冠状动脉疾病患病率及影响的系统评价和荟萃分析。
Heliyon. 2023 Aug 25;9(9):e19493. doi: 10.1016/j.heliyon.2023.e19493. eCollection 2023 Sep.
4
COVID-19 and coronary artery disease; A systematic review and meta-analysis.新型冠状病毒肺炎与冠状动脉疾病:一项系统评价和荟萃分析
New Microbes New Infect. 2023 Jun;53:101151. doi: 10.1016/j.nmni.2023.101151. Epub 2023 May 23.
5
Risk factors for SARS-CoV-2 related mortality and hospitalization before vaccination: A meta-analysis.接种疫苗前与SARS-CoV-2相关的死亡和住院的危险因素:一项荟萃分析。
PLOS Glob Public Health. 2022 Nov 2;2(11):e0001187. doi: 10.1371/journal.pgph.0001187. eCollection 2022.
6
Comorbid Asthma Increased the Risk for COVID-19 Mortality in Asia: A Meta-Analysis.合并哮喘增加亚洲地区2019冠状病毒病死亡风险:一项荟萃分析
Vaccines (Basel). 2022 Dec 30;11(1):89. doi: 10.3390/vaccines11010089.
7
The effects of hypertension on the prognosis of coronavirus disease 2019: a systematic review and meta-analysis on the interactions with age and antihypertensive treatment.高血压对 2019 年冠状病毒病预后的影响:一项关于与年龄和降压治疗相互作用的系统评价和荟萃分析。
J Hypertens. 2022 Dec 1;40(12):2323-2336. doi: 10.1097/HJH.0000000000003266. Epub 2022 Aug 8.
8
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.研究2019冠状病毒病重症和死亡风险因素的研究中的异质性和偏倚风险:一项系统评价和荟萃分析
Pathogens. 2022 May 10;11(5):563. doi: 10.3390/pathogens11050563.
9
Management of Children Admitted to Hospitals across Bangladesh with Suspected or Confirmed COVID-19 and the Implications for the Future: A Nationwide Cross-Sectional Study.孟加拉国疑似或确诊新冠病毒感染住院儿童的管理及其对未来的影响:一项全国性横断面研究
Antibiotics (Basel). 2022 Jan 14;11(1):105. doi: 10.3390/antibiotics11010105.
10
Chronic Diseases as a Predictor for Severity and Mortality of COVID-19: A Systematic Review With Cumulative Meta-Analysis.慢性病作为新冠病毒疾病严重程度和死亡率的预测指标:一项累积荟萃分析的系统评价
Front Med (Lausanne). 2021 Sep 1;8:588013. doi: 10.3389/fmed.2021.588013. eCollection 2021.